Strs Ohio Sells 8,499 Shares of Tenet Healthcare Corporation $THC

Strs Ohio lowered its holdings in shares of Tenet Healthcare Corporation (NYSE:THC) by 80.3% in the 3rd quarter, Holdings Channel.com reports. The fund owned 2,083 shares of the company’s stock after selling 8,499 shares during the period. Strs Ohio’s holdings in Tenet Healthcare were worth $423,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. NewEdge Advisors LLC lifted its holdings in Tenet Healthcare by 6.1% during the 1st quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock worth $389,000 after buying an additional 166 shares during the period. Jones Financial Companies Lllp boosted its holdings in Tenet Healthcare by 299.1% in the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after acquiring an additional 1,274 shares during the last quarter. Sivia Capital Partners LLC bought a new position in Tenet Healthcare during the 2nd quarter worth approximately $290,000. Signaturefd LLC lifted its position in shares of Tenet Healthcare by 11.2% in the 2nd quarter. Signaturefd LLC now owns 732 shares of the company’s stock worth $129,000 after purchasing an additional 74 shares during the period. Finally, Lecap Asset Management Ltd. acquired a new stake in shares of Tenet Healthcare during the second quarter worth $389,000. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

THC has been the topic of a number of research analyst reports. JPMorgan Chase & Co. upped their price target on shares of Tenet Healthcare from $200.00 to $230.00 and gave the company an “overweight” rating in a research report on Thursday, November 13th. Barclays upped their target price on Tenet Healthcare from $229.00 to $240.00 and gave the company an “overweight” rating in a research report on Friday, November 21st. Raymond James Financial set a $245.00 price target on Tenet Healthcare in a research note on Wednesday, October 29th. KeyCorp raised their price objective on shares of Tenet Healthcare from $205.00 to $225.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Finally, Mizuho boosted their target price on shares of Tenet Healthcare from $194.00 to $225.00 and gave the company an “outperform” rating in a research report on Friday, October 17th. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, Tenet Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $233.81.

Tenet Healthcare Price Performance

Shares of THC opened at $189.48 on Friday. The business’s fifty day moving average is $200.90 and its 200 day moving average is $192.03. Tenet Healthcare Corporation has a 12-month low of $109.82 and a 12-month high of $222.82. The company has a quick ratio of 1.64, a current ratio of 1.71 and a debt-to-equity ratio of 2.27. The stock has a market cap of $16.65 billion, a P/E ratio of 12.99, a P/E/G ratio of 0.81 and a beta of 1.41.

Insider Transactions at Tenet Healthcare

In other news, Director Tammy Romo sold 645 shares of the stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $205.20, for a total value of $132,354.00. Following the completion of the sale, the director directly owned 34,866 shares of the company’s stock, valued at $7,154,503.20. This represents a 1.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider R. Scott Ramsey sold 13,322 shares of Tenet Healthcare stock in a transaction that occurred on Thursday, November 6th. The shares were sold at an average price of $205.11, for a total value of $2,732,475.42. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 43,000 shares of company stock valued at $8,725,996 over the last three months. Corporate insiders own 0.81% of the company’s stock.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.